Advances in immunoglobulin E mediated antibiotic allergy

Area of Science:

• Clinical immunology
• Pharmacology
• Allergy and immunology

Background:

• Antibiotics are a primary cause of fatal anaphylaxis.
• Distinguishing true IgE-mediated antibiotic allergy from non-allergic reactions is crucial for patient safety and effective treatment.

Approach:

• Review of recent advancements in understanding IgE-mediated antibiotic allergy.
• Analysis of diagnostic approaches including skin testing and direct challenges.
• Examination of drug structures contributing to cross-reactivity.

Key Points:

• Recent research identifies patients lacking true IgE-mediated antibiotic allergy, enabling direct oral challenges.
• Structural similarities, particularly the R1 side-chain in cephalosporins, are implicated in cross-reactive allergy.
• Risk-based strategies for skin testing and challenges are evolving.

Conclusions:

• Identifying patients without true allergy allows for skipping skin testing and proceeding to direct ingestion challenges.
• This approach enhances antibiotic stewardship by avoiding unnecessary avoidance.
• Further research into the natural history of true antibiotic allergy is needed.